AbbVie and Alphabet spin-out Calico Life Sciences have agreed to fund their seven-year-old partnership seeking treatments for diseases of ageing with another $500 million apiece.
This second article in the three-part series examining healthcare trends in Latin America considers the effects of ageing, chronic conditions and obesity on the region.